The role of propranolol as a radiosensitizer in gastric cancer treatment

PURPOSE: The National Comprehensive Cancer Network guidelines indicate that radiotherapy in gastric cancer shows limited effectiveness at reducing the growth of gastric cancer. Therefore, enhancing the sensitivity and effect of radiotherapy with propranolol, a β-adrenoceptor antagonist, could reduce...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Xinhua, Chaudhary, Prakash, Qiu, Guanglin, Che, Xiangming, Fan, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880513/
https://www.ncbi.nlm.nih.gov/pubmed/29636598
http://dx.doi.org/10.2147/DDDT.S160865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880513/
https://www.ncbi.nlm.nih.gov/pubmed/29636598
http://dx.doi.org/10.2147/DDDT.S160865

Ejemplares similares